Clinical Trials Browser

NETWORK × Interventional × Medroxyprogesterone Acetate × Clear all

NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Phase 2 Completed

74 enrolled 13 charts

Advanced, Persistent, or Recurrent Endometrial Cancer

NCT00064025 2016-04-11

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Phase 2 Completed

75 enrolled 6 charts

Endometrial Adenocarcinoma